Search

Your search keyword '"Hogan, William J."' showing total 1,264 results

Search Constraints

Start Over You searched for: Author "Hogan, William J." Remove constraint Author: "Hogan, William J." Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,264 results on '"Hogan, William J."'

Search Results

2. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

4. Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

5. Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events

6. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

7. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

8. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

9. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

10. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

11. Effective treatment of low-risk acute GVHD with itacitinib monotherapy

13. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

14. Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent

15. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis

16. Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms

18. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

19. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

20. Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation

22. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases

23. Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms

26. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

29. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths

30. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

35. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases

36. The utility of biomarkers in acute GVHD prognostication

38. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions

39. Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

40. Mayo Clinic experience with 1123 adults with acute myeloid leukemia

41. Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure

43. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

Catalog

Books, media, physical & digital resources